Vermont H 202: An act relating to increasing the transparency of prescription drug costs and spending

Status: Read first time and referred to the Committee on Health Care (as of 2025-02-12)

State: Vermont · Session: 2025-2026 · Bill: H 202

Sponsors: Mari Cordes

View Vermont H 202 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.